{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:05:00Z","timestamp":1792785900932,"version":"4.5.0"},"reference-count":160,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":248,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Florence, of Modena and Reggio Emilia and from the Italian Ministry of University and Research","award":["2022N2KJAM"],"award-info":[{"award-number":["2022N2KJAM"]}],"id":[{"id":"https:\/\/ror.org\/04jr1s763","id-type":"ROR","asserted-by":"crossref"}]},{"name":"University of Florence, of Modena and Reggio Emilia and from the Italian Ministry of University and Research","award":["E53D23013280006"],"award-info":[{"award-number":["E53D23013280006"]}],"id":[{"id":"https:\/\/ror.org\/04jr1s763","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The ageing of the cirrhotic population, together with the epidemiological shift toward metabolic dysfunction-associated steatohepatitis, is redefining the profile of patients referred for transjugular intrahepatic portosystemic shunt (TIPS). Although TIPS remains a cornerstone in the management of complications of portal hypertension, its abrupt hemodynamic and metabolic effects challenge the physiological reserve of multiple organ systems. Age-related cardiovascular remodeling, cirrhotic cardiomyopathy, impaired renal function and autoregulation, and reduced neurocognitive reserve interact with the hyperdynamic circulatory state of cirrhosis increasing the susceptibility to heart failure, acute kidney injury (AKI), and hepatic encephalopathy following TIPS. This vulnerability is further amplified by metabolic comorbidities, obesity, sarcopenia, frailty, and age-related alterations of the gut microbiota and gut\u2013liver axis, which collectively promote systemic inflammation, immune dysregulation, endothelial dysfunction, and reduced metabolic adaptability. Rather than independently, these factors shape an interconnected heart\u2013liver\u2013kidney\u2013brain network in which dysfunction in one domain may rapidly propagate to others. This review summarizes how ageing influences the cardiovascular, renal, neurological, and metabolic response to TIPS, critically appraises current strategies for pre-procedural risk assessment, and discusses approaches to improve patient selection and peri-procedural management. Because chronological age alone inadequately reflects procedural risk and clinical outcomes, TIPS evaluation should incorporate a structured assessment of biological ageing, including cardiovascular and renal reserve, neurocognitive vulnerability, sarcopenia, frailty, body-composition phenotype, and metabolic burden. Integrating these domains into pre-procedural assessment may improve patient selection, inform shunt sizing, and ultimately optimize outcomes in this rapidly evolving patient population.<\/jats:p>","DOI":"10.1093\/gastro\/goag103","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:32:30Z","timestamp":1788867150000},"source":"Crossref","is-referenced-by-count":0,"title":["Navigating TIPS in the era of ageing and metabolic comorbidity: a contemporary narrative review of risk, resilience, and outcomes"],"prefix":"10.1093","volume":"14","author":[{"given":"Davide","family":"Roccarina","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Saltini","sequence":"additional","affiliation":[{"name":"Severe Liver Diseases Departmental Unit (M.E.C.), AOU Policlinico of Modena, CHIMOMO Department University of Modena and Reggio Emilia , Modena,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Mangini","sequence":"additional","affiliation":[{"name":"Department of Medicine (DIMED), University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Piscopo","sequence":"additional","affiliation":[{"name":"Severe Liver Diseases Departmental Unit (M.E.C.), AOU Policlinico of Modena, CHIMOMO Department University of Modena and Reggio Emilia , Modena,","place":["Italy"]},{"name":"Gastroenterology Unit, University Hospital of Modena \u201cPoliclinico\u201d, University of Modena and Reggio Emilia , Modena,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Mastro","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Barbera","sequence":"additional","affiliation":[{"name":"Department of Medicine (DIMED), University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Salom\u00e8","family":"Velasco Mayorga","sequence":"additional","affiliation":[{"name":"Severe Liver Diseases Departmental Unit (M.E.C.), AOU Policlinico of Modena, CHIMOMO Department University of Modena and Reggio Emilia , Modena,","place":["Italy"]},{"name":"Gastroenterology Unit, University Hospital of Modena \u201cPoliclinico\u201d, University of Modena and Reggio Emilia , Modena,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Avossa","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ragozzino","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Falcini","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rosi","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Vozza","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Falcone","sequence":"additional","affiliation":[{"name":"Department of Radiology, Interventional Radiology Unit, Careggi University Hospital , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Fanelli","sequence":"additional","affiliation":[{"name":"Department of Radiology, Interventional Radiology Unit, Careggi University Hospital , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Marra","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Montagnese","sequence":"additional","affiliation":[{"name":"Department of Medicine (DIMED), University of Padova , Padova,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Schepis","sequence":"additional","affiliation":[{"name":"Severe Liver Diseases Departmental Unit (M.E.C.), AOU Policlinico of Modena, CHIMOMO Department University of Modena and Reggio Emilia , Modena,","place":["Italy"]},{"name":"EpatoGastro Lab\u2014RBA-Labs CHIMOMO Department, University of Modena and Reggio Emilia , Modena,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3014-8968","authenticated-orcid":false,"given":"Francesco","family":"Vizzutti","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence , Florence,","place":["Italy"]},{"name":"Portal Hypertension Departmental Unit, Dipartimento Oncologico e di chirurgia ad indirizzo robotico, Azienda Ospedaliero Universitaria Careggi , Florence,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"2026092505360721400_goag103-B1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0002-9610(71)90147-4","article-title":"Transjugular intrahepatic portacaval shunt. An experimental work","volume":"121","author":"Rosch","year":"1971","journal-title":"Am J Surg"},{"key":"2026092505360721400_goag103-B2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11739-019-02252-8","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes","volume":"15","author":"Vizzutti","year":"2020","journal-title":"Intern Emerg Med"},{"key":"2026092505360721400_goag103-B3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jhep.2025.01.029","article-title":"EASL clinical practice guidelines on TIPS","volume":"83","author":"European Association for the Study of the Liver","year":"2025","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII \u2013 renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B5","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.cgh.2023.03.019","article-title":"Update in the treatment of the complications of cirrhosis","volume":"21","author":"Abraldes","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2023.04.028","article-title":"TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis","volume":"79","author":"Larrue","year":"2023","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis\u2014aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B8","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41575-025-01099-z","article-title":"Liver, ageing and disease","volume":"22","author":"Le Couteur","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.34067\/KID.0000001011","article-title":"Re-evaluating transjugular intrahepatic portosystemic shunt candidacy for patients with kidney disease","volume":"7","author":"Griffin","year":"2026","journal-title":"Kidney"},{"key":"2026092505360721400_goag103-B10","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)","year":"2024","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B12","doi-asserted-by":"crossref","first-page":"e47933","DOI":"10.1097\/MD.0000000000047933","article-title":"An analysis of the global, regional, and national burden of liver cirrhosis in older adults from 1990 to 2021","volume":"105","author":"Hu","year":"2026","journal-title":"Medicine (Baltimore)"},{"key":"2026092505360721400_goag103-B13","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary epidemiology of chronic liver disease and cirrhosis","volume":"18","author":"Moon","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12876-020-01239-6","article-title":"Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study","volume":"20","author":"Vaz","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"2026092505360721400_goag103-B15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mpmed.2024.12.004","article-title":"Frailty, multimorbidity and polypharmacy","volume":"53","author":"Montandon","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"2026092505360721400_goag103-B16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jgh3.12877","article-title":"Prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis","volume":"7","author":"Hanai","year":"2023","journal-title":"JGH Open"},{"key":"2026092505360721400_goag103-B17","doi-asserted-by":"crossref","first-page":"1353406","DOI":"10.3389\/fmed.2024.1353406","article-title":"The prevalence and characteristics of frailty in cirrhosis patients: a meta-analysis and systematic review","volume":"11","author":"Xie","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"2026092505360721400_goag103-B18","doi-asserted-by":"crossref","first-page":"e0811","DOI":"10.1097\/HC9.0000000000000811","article-title":"The impact of sarcopenia and frailty on decompensation in compensated cirrhosis: a systematic review","volume":"9","author":"Becchetti","year":"2025","journal-title":"Hepatol Commun"},{"key":"2026092505360721400_goag103-B19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/apt.15571","article-title":"Review article: malnutrition\/sarcopenia and frailty in patients with cirrhosis","volume":"51","author":"Bunchorntavakul","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2026092505360721400_goag103-B20","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"EASL Clinical Practice Guidelines on nutrition in chronic liver disease","volume":"70","author":"European Association for the Study of the Liver","year":"2019","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B21","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1016\/j.acra.2023.10.050","article-title":"Predictive accuracy comparison of prognostic scoring systems for survival in patients undergoing TIPS placement: a systematic review and meta-analysis","volume":"31","author":"Zhao","year":"2024","journal-title":"Acad Radiol"},{"key":"2026092505360721400_goag103-B22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/HEP.0000000000001106","article-title":"Looking at Neptune with a binocular","volume":"81","author":"Vizzutti","year":"2025","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/jcm13010014","article-title":"Post-transjugular intrahepatic portosystemic shunt (TIPS) hepatic encephalopathy\u2014a review of the past decade\u2019s literature focusing on incidence, risk factors, and prophylaxis","volume":"13","author":"Friis","year":"2023","journal-title":"J Clin Med"},{"key":"2026092505360721400_goag103-B24","doi-asserted-by":"crossref","first-page":"107924","DOI":"10.1016\/j.jvir.2025.107924","article-title":"Systematic literature review and meta-analysis of the cardiovascular effects of transjugular intrahepatic portosystemic shunt creation for decompensated liver cirrhosis","volume":"37","author":"Badar","year":"2026","journal-title":"J Vasc Interv Radiol"},{"key":"2026092505360721400_goag103-B25","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1007\/s10620-025-08940-0","article-title":"Utility of advanced age as a predictor of outcomes in patients undergoing transjugular intrahepatic portosystemic shunt","volume":"70","author":"Waidyaratne","year":"2025","journal-title":"Dig Dis Sci"},{"key":"2026092505360721400_goag103-B26","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3390\/biomedicines11082171","article-title":"The impact of renal function on hepatic encephalopathy following TIPS placement for refractory ascites","volume":"11","author":"Zhao","year":"2023","journal-title":"Biomedicines"},{"key":"2026092505360721400_goag103-B27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.14740\/gr1571","article-title":"Transjugular intrahepatic portosystemic shunt outcomes in the elderly population: a systematic review and meta-analysis","volume":"15","author":"Ahmed","year":"2022","journal-title":"Gastroenterol Res"},{"key":"2026092505360721400_goag103-B28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/jcm9020381","article-title":"Outcomes after transjugular intrahepatic portosystemic shunt in cirrhotic patients 70 years and older","volume":"9","author":"Adlakha","year":"2020","journal-title":"J Clin Med"},{"key":"2026092505360721400_goag103-B29","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.jvir.2021.03.271","article-title":"Abstract No. 462 Outcomes in patients over 70-years undergoing TIPS procedure: a single-center 10-year retrospective review","volume":"32","author":"Kus","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"2026092505360721400_goag103-B30","first-page":"215","article-title":"Older age is associated with increased early mortality after transjugular intrahepatic portosistemico shunt","volume":"15","author":"Saad","year":"2016","journal-title":"Ann Hepatol"},{"key":"2026092505360721400_goag103-B31","doi-asserted-by":"crossref","first-page":"8894058","DOI":"10.1155\/cjgh\/8894058","article-title":"Association between older age and TIPS-related hospitalization following shunt placement","volume":"2025","author":"Schliep","year":"2025","journal-title":"Can J Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B32","doi-asserted-by":"crossref","first-page":"e0235199","DOI":"10.1371\/journal.pone.0235199","article-title":"Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites","volume":"15","author":"Stockhoff","year":"2020","journal-title":"PLoS One"},{"key":"2026092505360721400_goag103-B33","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1007\/s00261-020-02533-3","article-title":"Is 70 the new 50? Complications and outcomes of transjugular intrahepatic portosystemic shunt in older versus younger patients","volume":"46","author":"Bisht","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"2026092505360721400_goag103-B34","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/hep.32704","article-title":"Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: a validated prediction model","volume":"77","author":"Vizzutti","year":"2023","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1440-1746.2011.06663.x","article-title":"Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review","volume":"26","author":"Bai","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.dld.2016.10.011","article-title":"Consensus conference on TIPS management: techniques, indications, contraindications","volume":"49","author":"Fagiuoli","year":"2017","journal-title":"Dig Liver Dis"},{"key":"2026092505360721400_goag103-B37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ajg.2016.29","article-title":"Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt","volume":"111","author":"Nardelli","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"2026092505360721400_goag103-B38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jhep.2008.04.022","article-title":"Detection of minimal hepatic encephalopathy: normalization and optimization of the psychometric hepatic encephalopathy score. A neuropsychological and quantified EEG study","volume":"49","author":"Amodio","year":"2008","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B39","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2004.12.028","article-title":"Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study","volume":"42","author":"Riggio","year":"2005","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B40","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s11011-019-00490-5","article-title":"Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy","volume":"34","author":"Senzolo","year":"2019","journal-title":"Metab Brain Dis"},{"key":"2026092505360721400_goag103-B41","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.3390\/jcm15082928","article-title":"TIPS in older adults: reserve-based risk stratification and practical approach","volume":"15","author":"He","year":"2026","journal-title":"J Clin Med"},{"key":"2026092505360721400_goag103-B42","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cgh.2016.10.028","article-title":"Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement","volume":"15","author":"Nardelli","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrgastro.2013.99","article-title":"The liver-brain axis in liver failure: neuroinflammation and encephalopathy","volume":"10","author":"Butterworth","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep4.1286","article-title":"Effect of increasing age on brain dysfunction in cirrhosis","volume":"3","author":"Liu","year":"2019","journal-title":"Hepatol Commun"},{"key":"2026092505360721400_goag103-B45","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jalz.2018.07.219","article-title":"Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance","volume":"16","author":"Stern","year":"2020","journal-title":"Alzheimers Dement"},{"key":"2026092505360721400_goag103-B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-019-0917-z","article-title":"Defining cognitive reserve and implications for cognitive ageing","volume":"19","author":"Pettigrew","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2026092505360721400_goag103-B47","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/BF03654795","article-title":"Cognitive Reserve Index questionnaire (CRIq): a new instrument for measuring cognitive reserve","volume":"24","author":"Nucci","year":"2012","journal-title":"Aging Clin Exp Res"},{"key":"2026092505360721400_goag103-B48","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.510280508","article-title":"Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations","volume":"28","author":"Nolte","year":"1998","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B49","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.3390\/jcm10132773","article-title":"The cerebral effect of ammonia in brain aging: blood-brain barrier breakdown, mitochondrial dysfunction, and neuroinflammation","volume":"10","author":"Jo","year":"2021","journal-title":"J Clin Med"},{"key":"2026092505360721400_goag103-B50","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1007\/s12035-020-01985-4","article-title":"Ammonia-induced glial-inflammaging","volume":"57","author":"Bobermin","year":"2020","journal-title":"Mol Neurobiol"},{"key":"2026092505360721400_goag103-B51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1021982719654","article-title":"Neuropsychological-neurophysiological alterations and brain atrophy in cirrhotic patients","volume":"18","author":"Amodio","year":"2003","journal-title":"Metab Brain Dis"},{"key":"2026092505360721400_goag103-B52","doi-asserted-by":"crossref","first-page":"100352","DOI":"10.1016\/j.jhepr.2021.100352","article-title":"The neurogliovascular unit in hepatic encephalopathy","volume":"3","author":"Claeys","year":"2021","journal-title":"JHEP Rep"},{"key":"2026092505360721400_goag103-B53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11011-025-01645-3","article-title":"Blood-brain barrier dysfunction in hepatic encephalopathy: pathophysiology, diagnostic assessment and therapeutic perspectives","volume":"40","author":"Le Guennec","year":"2025","journal-title":"Metab Brain Dis"},{"key":"2026092505360721400_goag103-B54","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.12324","article-title":"Review article: prescribing medications in patients with cirrhosis \u2013 a practical guide","volume":"37","author":"Lewis","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"2026092505360721400_goag103-B55","doi-asserted-by":"crossref","first-page":"e70365","DOI":"10.1111\/liv.70365","article-title":"Plasma ammonia levels over the course of a hospitalisation for overt hepatic encephalopathy","volume":"45","author":"Erminelli","year":"2025","journal-title":"Liver Int"},{"key":"2026092505360721400_goag103-B56","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/HEP.0000000000001252","article-title":"Acute encephalopathy without hyperammonemia has a different presentation than overt HE and displays a similarly severe prognosis","volume":"82","author":"Desplats","year":"2025","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B57","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/hep.27127","article-title":"Quick diagnosis of hepatic encephalopathy: fact or fiction?","volume":"61","author":"Montagnese","year":"2015","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B58","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/liv.14785","article-title":"Clinical, neuropsychological and neurophysiological indices and predictors of hepatic encephalopathy (HE)","volume":"41","author":"Formentin","year":"2021","journal-title":"Liver Int"},{"key":"2026092505360721400_goag103-B59","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.dld.2022.06.003","article-title":"Evolution of hepatic encephalopathy over time: ecological data from a tertiary referral centre for hepatology","volume":"55","author":"Mangini","year":"2023","journal-title":"Dig Liver Dis"},{"key":"2026092505360721400_goag103-B60","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11011-005-7919-z","article-title":"Attention, memory, and cognitive function in hepatic encephalopathy","volume":"20","author":"Weissenborn","year":"2005","journal-title":"Metab Brain Dis"},{"key":"2026092505360721400_goag103-B61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/gast.1996.v111.pm8698193","article-title":"Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis","volume":"111","author":"Krieger","year":"1996","journal-title":"Gastroenterology"},{"key":"2026092505360721400_goag103-B62","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/hep.20855","article-title":"Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatment","volume":"42","author":"Montagnese","year":"2005","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B63","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00365520500318932","article-title":"Portosystemic myelopathy: spastic paraparesis after portosystemic shunting","volume":"41","author":"Conn","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"2026092505360721400_goag103-B64","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/lt.22149","article-title":"Reversal of hepatic myelopathy after liver transplantation: fifteen plus one","volume":"16","author":"Baccarani","year":"2010","journal-title":"Liver Transpl"},{"key":"2026092505360721400_goag103-B65","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/hep.20905","article-title":"High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study","volume":"42","author":"Riggio","year":"2005","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B66","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.3390\/jcm10184050","article-title":"New therapies of liver diseases: hepatic encephalopathy","volume":"10","author":"Mangini","year":"2021","journal-title":"J Clin Med"},{"key":"2026092505360721400_goag103-B67","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.dld.2018.11.035","article-title":"Hepatic encephalopathy 2018: a clinical practice guideline by the Italian Association for the Study of the Liver (AISF)","volume":"51","author":"Montagnese","year":"2019","journal-title":"Dig Liver Dis"},{"key":"2026092505360721400_goag103-B68","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1152\/physrev.1993.73.2.413","article-title":"Cardiovascular regulatory mechanisms in advanced age","volume":"73","author":"Lakatta","year":"1993","journal-title":"Physiol Rev"},{"key":"2026092505360721400_goag103-B69","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.hfc.2011.08.011","article-title":"Aging-associated cardiovascular changes and their relationship to heart failure","volume":"8","author":"Strait","year":"2012","journal-title":"Heart Fail Clin"},{"key":"2026092505360721400_goag103-B70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2010.02.023","article-title":"Cirrhotic cardiomyopathy","volume":"53","author":"M\u00f8ller","year":"2010","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B71","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","article-title":"Interactions of the heart and the liver","volume":"34","author":"M\u00f8ller","year":"2013","journal-title":"Eur Heart J"},{"key":"2026092505360721400_goag103-B72","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.dld.2015.08.014","article-title":"Circulatory response to volume expansion and transjugular intrahepatic portosystemic shunt in refractory ascites: relationship with diastolic dysfunction","volume":"47","author":"Fil\u00ec","year":"2015","journal-title":"Dig Liver Dis"},{"key":"2026092505360721400_goag103-B73","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1053\/jhep.2003.09030","article-title":"Humoral and cardiac effects of TIPS in cirrhotic patients with different \u201ceffective\u201d blood volume","volume":"38","author":"Salerno","year":"2003","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B74","doi-asserted-by":"crossref","first-page":"107740","DOI":"10.3748\/wjg.v31.i27.107740","article-title":"Cardiovascular risk assessment and predictors of cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with cirrhosis","volume":"31","author":"Tomassoni","year":"2025","journal-title":"World J Gastroenterol"},{"key":"2026092505360721400_goag103-B75","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"GBD 2017 Cirrhosis Collaborators","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B76","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/lt.25976","article-title":"Nonalcoholic fatty liver disease: a special consideration in transjugular intrahepatic portosystemic shunts?","volume":"27","author":"Wang","year":"2021","journal-title":"Liver Transpl"},{"key":"2026092505360721400_goag103-B77","doi-asserted-by":"crossref","first-page":"100850","DOI":"10.1016\/j.gastha.2025.100850","article-title":"Association of cirrhosis etiology with outcomes after transjugular intrahepatic portosystemic shunt: a national cohort study","volume":"5","author":"Brar","year":"2026","journal-title":"Gastro Hep Adv"},{"key":"2026092505360721400_goag103-B78","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cgh.2021.07.018","article-title":"North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension","volume":"20","author":"Boike","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B79","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/hep.32596","article-title":"The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: recent evolution and open questions","volume":"77","author":"Deltenre","year":"2023","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B80","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MEG.0b013e32835d09fe","article-title":"Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis","volume":"25","author":"Busk","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B81","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.3390\/jcm12216758","article-title":"Transjugular intrahepatic portosystemic shunt: devices evolution, technical tips and future perspectives","volume":"12","author":"Saltini","year":"2023","journal-title":"J Clin Med"},{"key":"2026092505360721400_goag103-B82","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jcrc.2014.06.028","article-title":"The effects of transjugular intrahepatic portosystemic stent shunt on systemic cardiocirculatory parameters","volume":"29","author":"Saugel","year":"2014","journal-title":"J Crit Care"},{"key":"2026092505360721400_goag103-B83","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/hep.30934","article-title":"A prospective study identifying predictive factors of cardiac decompensation after transjugular intrahepatic portosystemic shunt: the Toulouse algorithm","volume":"70","author":"Billey","year":"2019","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B84","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s00270-017-1848-1","article-title":"Symptomatic heart failure after transjugular intrahepatic portosystemic shunt placement: incidence, outcomes, and predictors","volume":"41","author":"Modha","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2026092505360721400_goag103-B85","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/apt.15164","article-title":"Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis","volume":"49","author":"Armstrong","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2026092505360721400_goag103-B86","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1097\/HEP.0000000000000283","article-title":"The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study","volume":"77","author":"Bommena","year":"2023","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B87","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2006.102467","article-title":"Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt","volume":"56","author":"Cazzaniga","year":"2007","journal-title":"Gut"},{"key":"2026092505360721400_goag103-B88","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/hep.30948","article-title":"Predicting heart failure after TIPS: still more questions than answers","volume":"70","author":"Baiges","year":"2019","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B89","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2020.09.018","article-title":"Small diameter shunts should lead to safe expansion of the use of TIPS","volume":"74","author":"Bosch","year":"2021","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B90","first-page":"S236","article-title":"Cardiopulmonary hemodynamics and liver stiffness changes in predicting cardiac decompensation after TIPS: a prospective study","volume":"82","author":"Saltini","year":"2025","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B91","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1532-5415.1985.tb07117.x","article-title":"Longitudinal studies on the rate of decline in renal function with age","volume":"33","author":"Lindeman","year":"1985","journal-title":"J American Geriatrics Society"},{"key":"2026092505360721400_goag103-B92","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/j.ackd.2010.05.002","article-title":"The aging kidney: physiological changes","volume":"17","author":"Weinstein","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"2026092505360721400_goag103-B93","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.ackd.2015.08.004","article-title":"Structural and functional changes with the aging kidney","volume":"23","author":"Denic","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"2026092505360721400_goag103-B94","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/jgh.12709","article-title":"Acute kidney injury and hepatorenal syndrome in cirrhosis","volume":"30","author":"Egerod Israelsen","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B95","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.ajkd.2016.02.041","article-title":"Changes in kidney function after transjugular intrahepatic portosystemic shunts versus large-volume paracentesis in cirrhosis: a matched cohort analysis","volume":"68","author":"Allegretti","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2026092505360721400_goag103-B96","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.dld.2021.09.008","article-title":"Transjugular intrahepatic porto-systemic shunt in cirrhotic patients with hepatorenal syndrome\u2013chronic kidney disease: impact on renal function","volume":"54","author":"Ponzo","year":"2022","journal-title":"Dig Liver Dis"},{"key":"2026092505360721400_goag103-B97","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N Engl J Med"},{"key":"2026092505360721400_goag103-B98","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13063-023-07261-9","article-title":"Liver-HERO: hepatorenal syndrome\u2013acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis\u2014a randomized controlled trial","volume":"24","author":"Ripoll","year":"2023","journal-title":"Trials"},{"key":"2026092505360721400_goag103-B99","doi-asserted-by":"crossref","first-page":"e70733","DOI":"10.1111\/liv.70733","article-title":"Sarcopenia predicts mortality and hepatic encephalopathy after TIPS in older adults with cirrhosis and improves prognostic scores","volume":"46","author":"Saltini","year":"2026","journal-title":"Liver Int"},{"key":"2026092505360721400_goag103-B100","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/medicina61050821","article-title":"Sarcopenia and frailty in cirrhotic patients: evaluation of prevalence and risk factors in a single-centre cohort study","volume":"61","author":"Atay","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"2026092505360721400_goag103-B101","doi-asserted-by":"crossref","first-page":"1342100","DOI":"10.3389\/fnut.2023.1342100","article-title":"Correlation between sarcopenia and cirrhosis: a meta-analysis","volume":"10","author":"Cui","year":"2023","journal-title":"Front Nutr"},{"key":"2026092505360721400_goag103-B102","doi-asserted-by":"crossref","first-page":"255","DOI":"10.21037\/apm-24-173","article-title":"Sarcopenia in cirrhosis: a clinical practice review","volume":"14","author":"Ghumman","year":"2025","journal-title":"Ann Palliat Med"},{"key":"2026092505360721400_goag103-B103","first-page":"159","article-title":"Cause and management of muscle wasting in chronic liver disease","volume":"32","author":"Dasarathy","year":"2016","journal-title":"Curr Opin Gastroenterol"},{"key":"2026092505360721400_goag103-B104","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.nut.2014.07.005","article-title":"Sarcopenia impairs prognosis of patients with liver cirrhosis","volume":"31","author":"Hanai","year":"2015","journal-title":"Nutrition"},{"key":"2026092505360721400_goag103-B105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3350\/cmh.2019.0015","article-title":"Sarcopenia: ammonia metabolism and hepatic encephalopathy","volume":"25","author":"Jindal","year":"2019","journal-title":"Clin Mol Hepatol"},{"key":"2026092505360721400_goag103-B106","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.3390\/nu17213346","article-title":"Protein and macronutrient metabolism in liver cirrhosis: about sarcopenia","volume":"17","author":"Han","year":"2025","journal-title":"Nutrients"},{"key":"2026092505360721400_goag103-B107","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s12664-023-01465-2","article-title":"Sarcopenia is a risk factor for post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy and mortality: a systematic review and meta-analysis","volume":"43","author":"Ahmed","year":"2024","journal-title":"Indian J Gastroenterol"},{"key":"2026092505360721400_goag103-B108","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/ajt.12762","article-title":"Frailty predicts waitlist mortality in liver transplant candidates","volume":"14","author":"Lai","year":"2014","journal-title":"Am J Transplant"},{"key":"2026092505360721400_goag103-B109","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.29219","article-title":"Development of a novel frailty index to predict mortality in patients with end-stage liver disease","volume":"66","author":"Lai","year":"2017","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B110","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.jhep.2021.01.025","article-title":"Sarcopenia and frailty in decompensated cirrhosis","volume":"75(Suppl 1)","author":"Tandon","year":"2021","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B111","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Lai","year":"2021","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B112","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s00270-026-04405-7","article-title":"Elective transjugular intrahepatic portosystemic shunt creation in cirrhosis improves body composition and function: pilot randomized trial","volume":"49","author":"Suzuki","year":"2026","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2026092505360721400_goag103-B113","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/MEG.0000000000002592","article-title":"Transjugular intrahepatic portosystemic shunt insertion improves muscle mass but not muscle function or frailty measures","volume":"35","author":"Hey","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B114","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/apt.70315","article-title":"Impact of frailty on the prognosis of patients with liver cirrhosis undergoing insertion of a TIPS","volume":"63","author":"Kabelitz","year":"2026","journal-title":"Aliment Pharmacol Ther"},{"key":"2026092505360721400_goag103-B115","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/apt.13549","article-title":"Review article: sarcopenia in cirrhosis-aetiology, implications and potential therapeutic interventions","volume":"43","author":"Sinclair","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2026092505360721400_goag103-B116","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0168-8278(00)80121-X","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS) augments hyperinsulinemia in patients with cirrhosis","volume":"33","author":"Kaser","year":"2000","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B117","doi-asserted-by":"crossref","first-page":"G486","DOI":"10.1152\/ajpgi.00375.2009","article-title":"Insulin sensitivity and body composition in cirrhosis: changes after TIPS","volume":"299","author":"Holland-Fischer","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2026092505360721400_goag103-B118","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-2005-837546","article-title":"Fasting hyperglucagonemia in patients with transjugular intrahepatic portosystemic shunts (TIPS)","volume":"113","author":"Raddatz","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2026092505360721400_goag103-B119","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00535-013-0893-z","article-title":"Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension","volume":"49","author":"Ishikawa","year":"2014","journal-title":"J Gastroenterol"},{"key":"2026092505360721400_goag103-B120","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/apt.70453","article-title":"Diabetes mellitus is a risk factor for hepatic encephalopathy following transjugular intrahepatic portosystemic shunt","volume":"63","author":"Spaan","year":"2026","journal-title":"Aliment Pharmacol Ther"},{"key":"2026092505360721400_goag103-B121","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/MEG.0000000000001452","article-title":"Diabetes mellitus increases the risk of hepatic encephalopathy after a transjugular intrahepatic portosystemic shunt in cirrhotic patients","volume":"31","author":"Yin","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B122","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/lt.25949","article-title":"Nonalcoholic fatty liver disease and diabetes mellitus are associated with post-transjugular intrahepatic portosystemic shunt renal dysfunction: an advancing liver therapeutic approaches group study","volume":"27","author":"Ge","year":"2021","journal-title":"Liver Transpl"},{"key":"2026092505360721400_goag103-B123","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00042737-200103000-00007","article-title":"Transjugular intrahepatic portosystemic stent-shunt insufficiency and the role of diabetes mellitus","volume":"13","author":"Shah","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B124","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.amjms.2025.07.011","article-title":"Presence of chronic complications differentiates in-hospital outcomes of transjugular intrahepatic portosystemic shunt in patients with diabetes mellitus","volume":"370","author":"Li","year":"2025","journal-title":"Am J Med Sci"},{"key":"2026092505360721400_goag103-B125","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/apt.70496","article-title":"Editorial: TIPS in the era of aging and metabolic comorbidity: rethinking risks and rewards","volume":"63","author":"Roccarina","year":"2026","journal-title":"Aliment Pharmacol Ther"},{"key":"2026092505360721400_goag103-B126","doi-asserted-by":"crossref","first-page":"1769708","DOI":"10.3389\/fmed.2026.1769708","article-title":"Visceral to subcutaneous fat area ratio as a novel prognostic biomarker in cirrhosis patients undergoing TIPS: a retrospective study","volume":"13","author":"Li","year":"2026","journal-title":"Front Med (Lausanne)"},{"key":"2026092505360721400_goag103-B127","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1007\/s00261-023-03813-4","article-title":"Low adipose tissue index as an indicator of hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt","volume":"48","author":"Wang","year":"2023","journal-title":"Abdom Radiol (NY)"},{"key":"2026092505360721400_goag103-B128","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/MCG.0000000000002014","article-title":"Body compositions correlate with overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a multicentre cohort study","volume":"59","author":"Shi","year":"2025","journal-title":"J Clin Gastroenterol"},{"key":"2026092505360721400_goag103-B129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2214\/AJR.19.21655","article-title":"Relative sarcopenia with excess adiposity predicts survival after transjugular intrahepatic portosystemic shunt creation","volume":"214","author":"Ronald","year":"2020","journal-title":"Am J Roentgenol"},{"key":"2026092505360721400_goag103-B130","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/apt.16080","article-title":"Consequences of TIPSS placement on the body composition of patients with cirrhosis and severe portal hypertension: a large retrospective CT-based surveillance","volume":"52","author":"Artru","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2026092505360721400_goag103-B131","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0000000000002404","article-title":"Post-TIPS outcomes in metabolic dysfunction-associated steatotic liver disease: a real-world comparative study","author":"Bardak","year":"2026","journal-title":"J Clin Gastroenterol"},{"key":"2026092505360721400_goag103-B132","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.dld.2022.11.017","article-title":"Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients","volume":"55","author":"Gitto","year":"2023","journal-title":"Dig Liver Dis"},{"key":"2026092505360721400_goag103-B133","doi-asserted-by":"crossref","first-page":"e01021","DOI":"10.14309\/ctg.0000000000001021","article-title":"Alterations in the gut microbiota of cirrhotic patients with sarcopenia and PH after TIPS","volume":"17","author":"Wang","year":"2026","journal-title":"Clin Transl Gastroenterol"},{"key":"2026092505360721400_goag103-B134","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3350\/cmh.2024.0587","article-title":"Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis","volume":"31","author":"Tiede","year":"2025","journal-title":"Clin Mol Hepatol"},{"key":"2026092505360721400_goag103-B135","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1126\/science.aac8469","article-title":"Gut microbiota and aging","volume":"350","author":"O\u2019Toole","year":"2015","journal-title":"Science"},{"key":"2026092505360721400_goag103-B136","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nature11319","article-title":"Gut microbiota composition correlates with diet and health in the elderly","volume":"488","author":"Claesson","year":"2012","journal-title":"Nature"},{"key":"2026092505360721400_goag103-B137","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.cub.2016.04.016","article-title":"Gut microbiota and extreme longevity","volume":"26","author":"Biagi","year":"2016","journal-title":"Curr Biol"},{"key":"2026092505360721400_goag103-B138","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4161\/gmic.28684","article-title":"The role of microbiota in hepatic encephalopathy","volume":"5","author":"Bajaj","year":"2014","journal-title":"Gut Microbes"},{"key":"2026092505360721400_goag103-B139","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.3748\/wjg.v30.i31.3668","article-title":"Alterations in the gut microbiome after transjugular intrahepatic portosystemic shunt in patients with hepatitis B virus-related portal hypertension","volume":"30","author":"Zhao","year":"2024","journal-title":"World J Gastroenterol"},{"key":"2026092505360721400_goag103-B140","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1186\/s12967-025-06774-y","article-title":"Gut microbiome alterations and hepatic encephalopathy post-TIPS in liver cirrhosis patients","volume":"23","author":"Li","year":"2025","journal-title":"J Transl Med"},{"key":"2026092505360721400_goag103-B141","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41591-024-03405-9","article-title":"The gut-brain axis underlying hepatic encephalopathy in liver cirrhosis","volume":"31","author":"He","year":"2025","journal-title":"Nat Med"},{"key":"2026092505360721400_goag103-B142","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1038\/s41467-023-40741-9","article-title":"Portosystemic shunt placement reveals blood signatures for the development of hepatic encephalopathy through mass spectrometry","volume":"14","author":"Dantas Machado","year":"2023","journal-title":"Nat Commun"},{"key":"2026092505360721400_goag103-B143","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jhep.2024.12.047","article-title":"Microbiota transplant for hepatic encephalopathy in cirrhosis: the THEMATIC trial","volume":"83","author":"Bajaj","year":"2025","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B144","doi-asserted-by":"crossref","first-page":"e28584","DOI":"10.1097\/MD.0000000000028584","article-title":"Application of fecal microbial transplantation in hepatic encephalopathy after transjugular intrahepatic portosystemic shunt","volume":"101","author":"Li","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"2026092505360721400_goag103-B145","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/MEG.0000000000002596","article-title":"A meta-analysis of microbiome therapies for hepatic encephalopathy","volume":"35","author":"Gao","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B146","doi-asserted-by":"crossref","first-page":"1423780","DOI":"10.3389\/fmed.2025.1423780","article-title":"Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota","volume":"12","author":"Xu","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"2026092505360721400_goag103-B147","first-page":"103512","article-title":"Management of hepatic encephalopathy following transjugular intrahepatic portosystemic shunts: current strategies and future directions","volume":"31","author":"Li","year":"2025","journal-title":"World J Gastroenterol"},{"key":"2026092505360721400_goag103-B148","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.cgh.2018.01.029","article-title":"Under-dilated TIPS associate with efficacy and reduced encephalopathy in a prospective, non-randomized study of patients with cirrhosis","volume":"16","author":"Schepis","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026092505360721400_goag103-B149","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/HEP.0000000000001224","article-title":"End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective TIPS in patients with cirrhosis","volume":"82","author":"Roccarina","year":"2025","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B150","author":"Saltini","year":"2026"},{"key":"2026092505360721400_goag103-B151","doi-asserted-by":"crossref","first-page":"101676","DOI":"10.1016\/j.jhepr.2025.101676","article-title":"Shunt magnitude is a key determinant of overt hepatic encephalopathy in patients undergoing TIPS","volume":"8","author":"Roccarina","year":"2026","journal-title":"JHEP Rep"},{"key":"2026092505360721400_goag103-B152","doi-asserted-by":"crossref","first-page":"e70606","DOI":"10.1111\/liv.70606","article-title":"Prevention of portal hypertension complications beyond primary TIPS indication is independent of endoprosthesis under-dilation","volume":"46","author":"Roccarina","year":"2026","journal-title":"Liver Int"},{"key":"2026092505360721400_goag103-B153","first-page":"S1590-8658(26)00721-8","article-title":"Rethinking TIPS: from clinical insight to device innovation","volume":"14","author":"Vizzutti","year":"2026","journal-title":"Dig Liver Dis"},{"key":"2026092505360721400_goag103-B154","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jhep.2023.11.033","article-title":"Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis","volume":"80","author":"Nardelli","year":"2024","journal-title":"J Hepatol"},{"key":"2026092505360721400_goag103-B155","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/apt.18509","article-title":"Post-TIPS overt hepatic encephalopathy increases long-term but not short-term mortality in cirrhotic patients with variceal bleeding: a large-scale, multicenter real-world study","volume":"61","author":"Xiang","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"2026092505360721400_goag103-B156","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/HEP.0000000000000530","article-title":"AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage","volume":"79","author":"Lee","year":"2024","journal-title":"Hepatology"},{"key":"2026092505360721400_goag103-B157","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.2006.112177","article-title":"Cardiovascular complications of cirrhosis","volume":"57","author":"M\u00f8ller","year":"2008","journal-title":"Gut"},{"key":"2026092505360721400_goag103-B158","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3350\/kjhep.2010.16.4.347","article-title":"Hemodynamic alterations in cirrhosis and portal hypertension","volume":"16","author":"Kim","year":"2010","journal-title":"Korean J Hepatol"},{"key":"2026092505360721400_goag103-B159","doi-asserted-by":"crossref","first-page":"15499","DOI":"10.3748\/wjg.v20.i42.15499","article-title":"Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects","volume":"20","author":"M\u00f8ller","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2026092505360721400_goag103-B160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cld.2020.01.007","article-title":"Long-term management: modern measures to prevent readmission in patients with hepatic encephalopathy","volume":"24","author":"Rosenblatt","year":"2020","journal-title":"Clin Liver Dis"}],"container-title":["Gastroenterology Report"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/gastro\/article-pdf\/doi\/10.1093\/gastro\/goag103\/71393817\/goag103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/gastro\/article-pdf\/doi\/10.1093\/gastro\/goag103\/71393817\/goag103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:36:56Z","timestamp":1790329016000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/gastro\/article\/doi\/10.1093\/gastro\/goag103\/8835515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":160,"URL":"https:\/\/doi.org\/10.1093\/gastro\/goag103","relation":{},"ISSN":["2052-0034"],"issn-type":[{"value":"2052-0034","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,20]]},"article-number":"goag103"}}